BioNeutra Global Corporation
BGA.V
TSX
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -995.80K | -922.20K | -683.70K | -891.70K | -943.50K |
| Total Depreciation and Amortization | 205.10K | 170.10K | 185.20K | 194.70K | 204.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | 40.20K | -- |
| Total Other Non-Cash Items | 105.30K | 7.50K | 120.90K | -192.10K | 140.20K |
| Change in Net Operating Assets | 946.90K | 566.60K | 647.20K | 1.50M | 287.50K |
| Cash from Operations | 261.50K | -178.10K | 269.50K | 652.40K | -311.70K |
| Capital Expenditure | -1.60K | -7.70K | -1.60K | 21.00K | -28.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | -- | -- | 0.00 | -23.30K |
| Cash from Investing | -2.50K | -7.70K | -1.60K | 21.00K | -52.20K |
| Total Debt Issued | 336.30K | 24.70K | -- | 164.00K | 572.90K |
| Total Debt Repaid | -94.70K | -59.80K | -128.10K | -121.20K | 49.70K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 800.00 | 800.00 | -162.70K | -133.60K | -589.00K |
| Cash from Financing | 180.80K | -25.50K | -215.00K | -66.80K | 25.80K |
| Foreign Exchange rate Adjustments | -193.80K | 121.10K | -157.00K | -618.50K | 138.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 245.90K | -90.20K | -104.10K | -11.90K | -199.20K |
